A. Martucci

Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once‐Weekly Dipeptidyl Peptidase‐4 (DPP‐4) Inhibitor, After Single and Multiple Doses in Healthy Subjects

D. Tatosian, J. Wagner, R. Krishna, 2016, Journal of clinical pharmacology.

Pharmacokinetic and Pharmacodynamic Effects of Multiple-dose Administration of Omarigliptin, a Once-weekly Dipeptidyl Peptidase-4 Inhibitor, in Obese Participants With and Without Type 2 Diabetes Mellitus.

D. Tatosian, C. Matthews, Diana Selverian, 2016, Clinical therapeutics.

A flexible and high throughput liquid chromatography-tandem mass spectrometric assay for the quantitation of telcagepant in human plasma.

E. Woolf, C. Miller-Stein, Lihong Du, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects

C. Lines, D. Panebianco, J. Palcza, 2010, Archives of drug information.